EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases
- 3 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 15 (4), 1193-1201
- https://doi.org/10.1245/s10434-007-9771-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Differential prognostic impact of comorbidity in head and neck cancerHead & Neck, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Prognostic significance of vascular endothelial growth factor protein levels in T1‐2 N0 laryngeal cancer treated with primary radiation therapyCancer, 2006
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patientsBritish Journal of Cancer, 2006
- Pharmacodiagnostic Value of the HER Family in Head and Neck Squamous Cell CarcinomaORL, 2004
- C-erbB-2 Immunostaining in Laryngeal CancerActa Oto-Laryngologica, 1999
- Glottic and Supraglottic Laryngeal Carcinoma: Differences in Epidemiology, Clinical Characteristics and PrognosisActa Oto-Laryngologica, 1999
- Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinomaPathology, 1997
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988